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Aneurysm Formation in Modified Human Umbilical Vein Grafts 
R. Strobel, A. H. Boontje* and J. J. A. M. Van Den Dungen ~ 
Department of Surgery, University Hospital Groningen, The Netherlands. 
Objectives: Aneurysm formation in Human Umbilical Vein Grafts has been reported to be as high as 657o after 5 years. 
One of the causes might be the structure of the Biograft-wall and in 1985 a new method of processing the graft was begun. 
In Groningen this new improved Biograft has been used since late 1986. 
Design: Duplex scanning was used to examine the frequency of aneurysm formation in the new improved Biograft. 
Materials: Sixty-nine patent Biografts have been examined in a period up to 6 years after implantation. 
Main Results: Aneurysms were found in only 177o of grafts although the frequency increased with time. Dilatation was 
common but may be due to a more elastic graft. 
Conclusion: These findings justify the continued use of the new Biograft as a substitute for arterial femoropopliteal 
reconstructions. 
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Introduction 
Since the introduction of the glutaraldehyde-tanned 
Human Umbilical Vein Graft (Biograft) as an arterial 
substitute for revascularisation f the lower limb in 
1975, considerable knowledge has been gained con- 
cerning patency rates and the behavior of this graft. 
A point of great concern has been aneurysm 
formation in this biological graft, as described in 
several papers. 1-1° The reported incidence of aneu- 
rysm formation depends on the definition of aneu- 
rysm, the diagnostic methods and the methods of 
analysis of the material, which may explain the 
variation in frequency from 3 to 65%. 
The manufacturers of the Biograft (Meadox Medical 
Inc. and since 1989, Bio-Vascular Inc.) introduced 
several improvements in the processing steps of the 
Biograft, in an attempt to prevent dilatation: 
1. Improved glutaraldehyde fixation results in 
greater thermal stability and a decrease in mural 
dissection of the wall, improving resistance to 
degradation. 
2. The exterior excess tissue surrounding the 
umbilical cord is mechanically stripped with a 
lathe, which results in a thinner and more 
consistent wall thickness. 
*Please address all correspondence to: Ab H. Boontje, Professor f 
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3. The Dacron mesh surrounding the Biograff is 
knitted with tighter interstices, giving more 
strength to the supportive structure of the 
graft. 
At the University Hospital of Groningen the mod- 
ified Biograft has been used since late 1986. The 
purpose of this study was to investigate he incidence 
of dilatation and aneurysm formation in the new 
Biograft. 
Patients and Methods 
Between October 1986 and January 1992 a series of 105 
femoropopliteal bypass procedures with a Biograft 
were performed for atherosclerotic o clusive disease. 
Sixty-seven patients (56 male and 11 female) with 69 
patent bypasses were available for the study and were 
examined with a Duplex scanner. The mean age was 
73 years for men and 64 years for women. 
Indications for operation were short-distance and 
disabling claudication in 48 cases and limb-threat- 
ening ischaemia in 13 cases. Seven cases were secon- 
dary operations as a replacement of the Biograft due 
to occlusion (n = 2) or aneurysm formation (n = 5) of an 
old Biograft. In one case a femoropopliteal bypass 
procedure was performed because of a popliteal artery 
aneurysm. The proximal end-to-side anastomosis was 
usually to the common femoral artery and in three 
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cases to the distal end of a previously inserted 
proximal bypass. The distal end-to-side anastomosis 
was to the popliteal artery, above the knee in 61 cases 
and below the knee in eight cases. For above knee 
reconstructions a 6mm. Biograft was used and for 
below knee reconstructions a composite 6 and 5 mm. 
Biograft was inserted. All patients received anticoagu- 
lant therapy (acenocoumarin) for 6 months 
postoperatively. 
Since June 1990 patients with a patent graft have 
been screened yearly with Duplex ultrasonography to 
detect dilatations and aneurysms. Because the study 
started in 1990 and the new type of Biograft has been 
used since 1986, not all patent grafts could be scanned 
after 1, 2, or 3 years. A high-resolution Duplex scanner 
(Ultramark 5 ,  Advanced Techniques Laboratories, 
USA) was used, having a 7.5 MHz and a 10 MHz 
transducer to visualise every graft in both transverse 
and longitudinal planes. Every limb was divided in 6 
zones: zone I was at the proximal anastomosis, zone 
IV above the popliteal space where the distal anasto- 
mosis was located in case of above knee procedures 
and zone VI at the distal popliteal artery where the 
distal anastomosis of below knee procedures was 
located (Fig. 1). All other zones were equally spaced 
between the proximal and distal zones. Measurements 
of the graft were taken 5 mm above and below every 
zone. 
Before insertion the Biograft has an inner diameter 
of 6 ram, or of 6 mm and 5 mm in the case of a 
composite graft. The outer diameter before insertion is 
8 mm in the case of above knee procedures, and 8 mm 
and 7 mm in composite grafts. Our Duplex equipment 
has a resolution of I mm. We defined a Biograft to be 
aneurysmal if the outer diameter was 150% (i.e. 12 
mm or 10.5 ram) of its original size or more. Grafts 
with diameters between 10 and 12 mm were defined 
as dilated but not aneurysmal. Aneurysms have been 
described to be diffuse or localized. 5'7 An aneurysm 
was considered to be diffuse if its length was at least 
one third of the total length of the graft. All other 
aneurysms were classified as localized and were 
sometimes multiple. There are two categories of 
localised aneurysms i.e. fusiform and saccular. A 
fusiform aneurysm is concentric with a symmetrical ly 
distended graft-wall. A saccular aneurysm is eccentric 
with a normal graft wall on one side. 
Results 
Sixty nine patent grafts were examined at least once 
(Table 1). After 1 year one above knee bypass was 
found to be diffusely aneurysmal (14, 15 and 14 mm at 
zones II, III and IV). The 6 mm part of a composite 
graft was also aneurysmal (14, 15 and 14 mm at zones 
I, II and III). Seven grafts were found to be dilated (5 
localised and 2 diffuse). After a period of 2 years 
(n = 25) one patient was found to have a localised 
Zone I 
Zone II 
Zone III 
Zone IV 
Zone V 
Zone VI 
Fig. 1. Schematic diagram, showing scanning zones. 
Table 1. Diameters found during Duplex scanning of all 69 
Biografts. The percentage of aneurysm at each year of 
examination is shown in brackets 
Dilatation Aneurysm 
Postop. >10mm <12mm >12mm 
years n <10mm loc. diff. loc. diff. 
1 15 6 5 2 - -  2 (13%) 
2 25 16 2 6 1 - -  (14%) 
3 25 19 1 2 3 - -  (12%) 
4 16 10 2 1 2 1 (13%) 
5 19 12 1 - -  6 - -  (35%) 
6 8 5 --  - -  1 2 (38%) 
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aneurysm (13 mm). Eight grafts were dilated. At 3 
years (n =25) 3 patients had a localized fusiform 
aneurysm (13 mm) and three grafts were dilated. 
Four years after implantation (n = 16) one patient 
had a local aneurysm (17 mm). In another patient a 
diameter of 18 mm was measured at zone III while just 
above zone IV a saccular aneurysm of 24 mm was 
found with a local disruption of the dacron mesh 
leading to an outer diameter of the mass of 28 mm. At 
this point no clear inner wall structure could be seen. 
One patient had a diffuse aneurysm (13 ram) and three 
grafts were dilated. At 5 years (n = 19) there were six 
cases of localised, fusiform aneurysm formation. One 
of these grafts had a saccular aneurysm of 23 mm at 
one zone, but no clear disruption of the Dacron mesh 
could be detected. One year previously, this graft had 
an aneurysm at the same location of 17 mm. Eight 
grafts were examined after 6 years. The same 23 mm 
aneurysm seen at 5 years had now grown to 27 mm. 
No inner wall structure could be detected, and there 
seemed to be a rupture of the Dacron mesh at one 
point. 
Anastomotic aneurysms were not seen in any graft. 
50% of all aneurysms were located in zone II and 50% 
in zone III. In two cases we saw dilatation of a 
composite graft between zone IV and V. 
Discussion 
Of all grafts examined we found a frequency of 
aneurysms of 17%, although the frequency increased 
with time. In his study Boontje 3found a frequency of 
3.5% aneurysm formation after 6 years among 257 
Biografts of the older type, diagnosed by clinical 
assessment alone. All aneurysms originated from a 
defect in the graft wall. Boontje 4 also described a 
frequency of 46% diffuse or local ectasia of grafts after 
3-5 years with follow-up angiography. After 6 years 
Dardik et al. 7 found 7.7% dilatation of the older type of 
Biografts at angiographic assessment. 
Our study was based on screening with Duplex 
scanning because previous studies have shown that 
this is the preferential method. 6'9'1° Karkow et al., 6 
Nevelsteen et al 9 and Sommeling et aI. 1° have also 
performed a screening with Duplex scanning, but 
these studies were of the old Biograft and the 
frequencies of aneurysm formation were high, (65%, 
40%, and 50% respectively after more than 5 years). 
Out of 64 Biografts, Karkow found seven grafts to 
have a diameter more than 30 mm ranging up to 57 
mm. The largest diameters measured in our series 
were two Biografts with an outer diameter of 27 and 
28 mm in which there was a defect in the Dacron 
mesh. All other aneurysmal grafts had a maximum 
diameter of 17 mm but without any sign of inner wall 
loss, or Dacron mesh rupture. Our policy is to 
intervene surgically only if the diameter of an aneu- 
rysm is larger than 30 mm, unless the patient is 
symptomatic. Both patients with large aneurysms of 
their Biografts are asymptomatic and without com- 
promise to the distal circulation. 
Karkow et al. 6 and Sommeling et al J  ° describe the 
outer diameter of newly implanted old type Biografts 
to be 8 mm. We never found this as Biografts of the 
new type seem to dilate to a diameter of 9-10 mm 
within 1 week of implantation. On the other hand, all 
not-dilated Biografts of the old type previously 
scanned at our vascular laboratory had an outer 
diameter of 8 mm. It seems as if the modified Biograft 
is more elastic, which might be explained by the 
changed method of harvesting the umbilical vein 
mechanically, which results in a thinner and smoother 
wall. In contrast with the results of many other 
authors we did not detect any anastomotic 
aneurysms.  2,3,6,9 
In conclusion, although there is a tendency for 
dilatation in the new modified Biograft, there seems to 
be a substantially lower incidence of significant 
aneurysm formation compared to the old type Bio- 
graft. The modified Biograft seems to be an improve- 
ment in its use as an arterial substitute for femoro- 
popliteal reconstructions. 
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